Thyroid hormone regulates adhesion, migration and matrix metalloproteinase 9 activity via ?v?3 integrin in myeloma cells.
Ontology highlight
ABSTRACT: Thyroid hormone (3,5,3'-triiodothyronine, T3; L-thyroxine, T4) enhances cancer cell proliferation, invasion and angiogenesis via a discrete receptor located near the RGD recognition site on ?v?3 integrin. Tetraiodothyroacetic acid (tetrac) and its nanoparticulate formulation interfere with binding of T3/T4 to the integrin. This integrin is overexpressed in multiple myeloma (MM) and other cancers. MM cells interact with ?v?3 integrin to support growth and invasion. Matrix metalloproteinases (MMPs) are a family of enzymes active in tissue remodeling and cancer. The association between integrins and MMPs secretion and action is well established. In the current study, we examined the effects of thyroid hormone on myeloma cell adhesion, migration and MMP activity. We show that T3 and T4 increased myeloma adhesion to fibronectin and induced ?v?3 clustering. In addition, the hormones induced MMP-9 expression and activation via ?v?3 and MAPK induction. Bortezomib, a standard myeloma treatment, caused a decrease in activity/quantity of MMPs and thyroid hormone opposed this effect. RGD peptide and tetrac impaired the production of MMP-9 in cell lines and in primary BM cells from myeloma patients. In conclusion, thyroid hormone-dependent regulation via ?v?3 of myeloma cell adhesion and MMP-9 production may play a role in myeloma migration and progression.
SUBMITTER: Cohen K
PROVIDER: S-EPMC4171632 | biostudies-literature | 2014 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA